Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Hyundai Motor (005380) – Provisional Sales Results (Fair Disclosure) / 2024-12-02 Disclosures
  • [Disclosure] KEPCO (015760 / KEP) – (Correction) Results of Extraordinary General Meeting of Shareholders / 2025-01-07 Disclosures
  • [Disclosure] Celltrion (068270) – CT-P55 (Cosentyx Biosimilar) U.S. BLA Submission / 2026-07-30 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Provisional Consolidated Financial Results (Fair Disclosure) / 2025-04-08 Semiconductors
  • [Disclosure] SK Square (402340) – Decision on Termination of Trust Contract for Treasury Share Acquisition / 2024-09-30 Semiconductors
  • [Disclosure] Celltrion (068270) – Submission of Audit Report / 2025-03-17 Disclosures
  • [Disclosure] SK Hynix (000660 / SKHY) – Results of Annual General Meeting of Shareholders / 2025-03-27 Semiconductors
  • [Research] Samsung Electro-Mechanics (009150) – iM Securities | High MLCC Utilization & Disciplined CAPEX · 2026 Earnings Growth · Target P/B Upgrade / 2025-10-30 RESEARCH

[Disclosure] Celltrion (068270) – Provisional Earnings Release (Consolidated Basis) / 2026-02-05

Posted on February 5, 2026August 6, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Celltrion reported provisional Q4 2025 consolidated revenue of KRW 1.33T (+25.06% YoY) and operating profit of KRW 475.2B (+141.94% YoY).

📊 [Key Disclosure Details & Financial Summary]

  • Disclosure Title: Provisional Earnings Release (Consolidated Basis)
  • Information Date: February 5, 2026 (Provided by Celltrion IR Department)
  • Performance Period:
    • Current Period: October 1, 2025 ~ December 31, 2025 (Q4 2025)
    • Cumulative Period: January 1, 2025 ~ December 31, 2025 (FY2025)

[Q4 2025 Quarterly Financials (Unit: KRW Million)]

  • Revenue: KRW 1,330,157M (approx. KRW 1.33T / +29.27% QoQ, +25.06% YoY)
  • Operating Profit: KRW 475,172M (approx. KRW 475.2B / +57.65% QoQ, +141.94% YoY)
  • Profit Before Income Tax: KRW 527,863M (approx. KRW 527.9B / +39.67% QoQ, +92.66% YoY)
  • Net Profit: KRW 527,928M (approx. KRW 527.9B / +59.05% QoQ, +124.11% YoY)
  • Net Profit Attributable to Controlling Interest: KRW 528,427M (approx. KRW 528.4B)

[FY2025 Annual Cumulative Financials (Unit: KRW Million)]

  • Cumulative Revenue: KRW 4,162,495M (approx. KRW 4.16T / +17.01% YoY)
  • Cumulative Operating Profit: KRW 1,168,471M (approx. KRW 1.17T / +137.49% YoY)
  • Cumulative Net Profit: KRW 1,031,484M (approx. KRW 1.03T / +146.25% YoY)
  • Note to Investors: Figures are provisional consolidated management accounts under K-IFRS prior to external audit completion and are subject to change upon final audit review.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of External Audit Report Submission and Finalized Financials

This disclosure details Celltrion’s provisional Q4 and FY2025 financial results based on internal settlement data, making it important to confirm the finalized audited financial statements. Comparing the audited figures against the provisional numbers upon submission of the independent audit report ensures verification of final financial figures for the fiscal year. Finalized financial statements and audit opinions can be verified through upcoming ‘Submission of Audit Report’ disclosures or Annual Business Reports.

📢 Disclaimer & Source Information

Source: This content was newly generated and structured based on official data submitted to the Data Analysis, Retrieval and Transfer System (DART) of the Financial Supervisory Service.

Investment Risk Notice: This information is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Hanwha Ocean (042660) – Change in Revenue or Income Structure Exceeding 30% (15% for Large Corporations) / 2026-02-04
Next Post: [Disclosure] Celltrion (068270) – Change in Sales or Loss Structure by More Than 30% (15% for Large Corporations) / 2026-02-05

Related Posts

  • [Disclosure] ALTEOGEN (196170) – Clarification on Rumors or News Reports (Unconfirmed) / 2024-12-20 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2024-08-26 Semiconductors
  • [Disclosure] KEPCO (015760 / KEP) – Investor Relations (IR) Announcement / 2025-02-25 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Advance Notice of Earnings Release / 2024-04-09 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – (Correction) Decision on Loan to Others / 2024-10-14 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2025-11-28 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | AI Infrastructure · LTA · HBM Demand / 2026-06-09 RESEARCH
  • [Disclosure] ALTEOGEN (196170) – Receipt of Milestone Payment Related to ALT-B4 License Agreement / 2025-10-01 Disclosures
  • [Disclosure] Celltrion (068270) – Investor Relations (IR) Meeting Announcement / 2025-05-14 Disclosures
  • [Disclosure] Hana Micron (067310) – Decision on Lawsuit (Cancellation of Shareholder Meeting Resolution) / 2026-01-19 Semiconductors
  • [Disclosure] Daeduck Electronics (353200) – Investor Relations (IR) Holding (Information Disclosure) / 2025-04-17 Semiconductors
  • [Disclosure] Hanwha Systems (272210) – Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2025-03-18 Disclosures
  • [Disclosure] Daeduck Electronics (353200) – Change in Revenue or Profit/Loss Structure Exceeding 30% (15% for Large Corporations) / 2026-01-29 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – SK Securities | Value-up Plan · CapEx Discipline · High-Value Mix Expansion / 2024-11-28 RESEARCH

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme